Skip to main content
. 2025 Aug 3;13(8):243. doi: 10.3390/diseases13080243
ANAs Antinuclear Antibodies
AS Ankylosing Spondylitis
ATRA All-Trans Retinoic Acid
CHC Chronic Hyperplastic Candidiasis
CMC Chronic Mucocutaneous Candidiasis
COVID-19 Coronavirus Disease
cGVHD Chronic Graft Versus Host Disease
DIF Direct Immunofluorescence
EBER Epstein–Barr Virus-encoded small RNA
EBV Epstein–Barr Virus
EEM Erythema Exudativum Multiforme
ELISA Enzyme-Linked Immunosorbent Assay
ENAs Extractable Nuclear Antigens
FDA Food and Drug Administration
GERD Gastro-Oesophageal Reflux Disease
HIV Human Immunodeficiency Virus
IBD Inflammatory Bowel Disease
IL-17 Interleukin 17
IL-17A Interleukin 17-A
IL-23 Interleukin 23
LE Lupus Erythematosus
MRONJ Medication-Related Osteonecrosis of the Jaw
MS Multiple Sclerosis
NHL Non-Hodgkin Lymphoma
OLDR Oral Lichenoid Drug Reaction
OLP Oral Lichen Planus
OLR Oral Lichenoid Reaction
OPMD Oral Potentially Malignant Disorder
PAS Periodic Acid-Schiff
PCI Percutaneous Coronary Intervention
PHD Histopathological Diagnosis
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PsA Psoriatic Arthritis
PsO Psoriasis
QoL Quality of Life
RA Rheumatoid Arthritis
SEC Secukinumab
TNF-α Tumour Necrosis Factor-α
WHO World Health Organization